[Peculiarities of anticoagulant therapy for venous thrombosis and chronic renal insufficiency (literature review)].

The choice of antithrombotic therapy for treatment of patients with venous thromboses and renal dysfunction supposes a special approach due to increased risk of both hemorrhagic and thrombotic events. Therapeutic decision-making is difficult because of concomitant renal dysfunction. Improved quality of life and prognosis in elderly patients with chronic renal insufficiency largely depend on adequate anticoagulant therapy with modern drugs. Presented herein are the findings of several studies in patients with deep vein thrombosis/pulmonary embolism, receiving therapy including that with rivaroxaban, demonstrating its high anticoagulation effect and a favorable safety profile as low risks of hemorrhage in high-risk patients, i. e., those with renal dysfunction, as well as in frail patients.